143 related articles for article (PubMed ID: 24211209)
1. SIRT1 suppresses cellular accumulation of β-TrCP E3 ligase via protein degradation.
Woo SR; Byun JG; Kim YH; Park ER; Joo HY; Yun M; Shin HJ; Kim SH; Shen YN; Park JE; Park GH; Lee KH
Biochem Biophys Res Commun; 2013 Nov; 441(4):831-7. PubMed ID: 24211209
[TBL] [Abstract][Full Text] [Related]
2. The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.
Shanzer M; Adler J; Ricardo-Lax I; Reuven N; Shaul Y
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1678-1683. PubMed ID: 28154141
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis.
Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H
Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875
[TBL] [Abstract][Full Text] [Related]
4. β-TrCP-mediated ubiquitination and degradation of liver-enriched transcription factor CREB-H.
Cheng Y; Gao WW; Tang HM; Deng JJ; Wong CM; Chan CP; Jin DY
Sci Rep; 2016 Mar; 6():23938. PubMed ID: 27029215
[TBL] [Abstract][Full Text] [Related]
5. SCF
Ci Y; Li X; Chen M; Zhong J; North BJ; Inuzuka H; He X; Li Y; Guo J; Dai X
Protein Cell; 2018 Oct; 9(10):879-889. PubMed ID: 29497989
[TBL] [Abstract][Full Text] [Related]
6. β-TrCP-dependent degradation of ASK1 suppresses the induction of the apoptotic response by oxidative stress.
Cheng R; Takeda K; Naguro I; Hatta T; Iemura SI; Natsume T; Ichijo H; Hattori K
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2271-2280. PubMed ID: 30031111
[TBL] [Abstract][Full Text] [Related]
7. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
[TBL] [Abstract][Full Text] [Related]
8. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.
Ougolkov A; Zhang B; Yamashita K; Bilim V; Mai M; Fuchs SY; Minamoto T
J Natl Cancer Inst; 2004 Aug; 96(15):1161-70. PubMed ID: 15292388
[TBL] [Abstract][Full Text] [Related]
9. DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase.
Chen H; Ma H; Inuzuka H; Diao J; Lan F; Shi YG; Wei W; Shi Y
Mol Cell Biol; 2013 Mar; 33(6):1139-48. PubMed ID: 23297342
[TBL] [Abstract][Full Text] [Related]
10. UV-induced degradation of securin is mediated by SKP1-CUL1-beta TrCP E3 ubiquitin ligase.
Limón-Mortés MC; Mora-Santos M; Espina A; Pintor-Toro JA; López-Román A; Tortolero M; Romero F
J Cell Sci; 2008 Jun; 121(11):1825-31. PubMed ID: 18460583
[TBL] [Abstract][Full Text] [Related]
11. Dual regulation of the transcriptional activity of Nrf1 by β-TrCP- and Hrd1-dependent degradation mechanisms.
Tsuchiya Y; Morita T; Kim M; Iemura S; Natsume T; Yamamoto M; Kobayashi A
Mol Cell Biol; 2011 Nov; 31(22):4500-12. PubMed ID: 21911472
[TBL] [Abstract][Full Text] [Related]
12. Dual degradation signals destruct GLI1: AMPK inhibits GLI1 through β-TrCP-mediated proteasome degradation.
Zhang R; Huang SY; Ka-Wai Li K; Li YH; Hsu WH; Zhang GJ; Chang CJ; Yang JY
Oncotarget; 2017 Jul; 8(30):49869-49881. PubMed ID: 28562331
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin E3 ligase β-TrCP negatively regulates surface protein of hepatitis B virus.
Tu W; Liu J; Qian F; Zhu L; Li M; Zheng H; Zhu C
J Med Virol; 2023 Mar; 95(3):e28620. PubMed ID: 36846904
[TBL] [Abstract][Full Text] [Related]
14. Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
Shi P; Zhu S; Lin Y; Liu Y; Liu Y; Chen Z; Shi Y; Qian Y
Sci Signal; 2011 Nov; 4(197):ra73. PubMed ID: 22045853
[TBL] [Abstract][Full Text] [Related]
15. LPS impairs phospholipid synthesis by triggering beta-transducin repeat-containing protein (beta-TrCP)-mediated polyubiquitination and degradation of the surfactant enzyme acyl-CoA:lysophosphatidylcholine acyltransferase I (LPCAT1).
Zou C; Butler PL; Coon TA; Smith RM; Hammen G; Zhao Y; Chen BB; Mallampalli RK
J Biol Chem; 2011 Jan; 286(4):2719-27. PubMed ID: 21068446
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-specific protease USP47 is a novel beta-TRCP interactor regulating cell survival.
Peschiaroli A; Skaar JR; Pagano M; Melino G
Oncogene; 2010 Mar; 29(9):1384-93. PubMed ID: 19966869
[TBL] [Abstract][Full Text] [Related]
17. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of β-TrCP in growth hormone transduction defect (GHTD).
Kostopoulou E; Rojas Gil AP; Spiliotis BE
Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114520
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer.
Yousafzai NA; Zhou Q; Xu W; Shi Q; Xu J; Feng L; Chen H; Shin VY; Jin H; Wang X
Cell Death Dis; 2019 May; 10(5):363. PubMed ID: 31043584
[TBL] [Abstract][Full Text] [Related]
20. Fas-associated factor 1 is a scaffold protein that promotes β-transducin repeat-containing protein (β-TrCP)-mediated β-catenin ubiquitination and degradation.
Zhang L; Zhou F; Li Y; Drabsch Y; Zhang J; van Dam H; ten Dijke P
J Biol Chem; 2012 Aug; 287(36):30701-10. PubMed ID: 22730322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
